Elsevier, European Journal of Integrative Medicine, (7), p. 43, 2015
DOI: 10.1016/j.eujim.2015.09.107
Full text: Download
The increase of antibiotic resistance worldwide, rising numbers of deaths and costs associated with this, and the fact that hardly any new antimicrobial drugs have been developed during the last decade has increased the interest in Complementary & Alternative Medicine (CAM) therapeutic interventions, if proven safe and effective. Observational studies on clinical CAM practices demonstrate positive effects of treatment of infections with CAM therapies (clinical effects, patient satisfaction) in combination with small percentages of antibiotics prescription. However, Cochrane reviews and other studies demonstrate that in most instances the quality of clinical trials on CAM treatment of infections is currently too low to provide sufficiently evidence. Therefore a Dutch consortium on (in-vitro and clinical) scientific research on CAM and antibiotic resistance has been formed. The aim and objective of the consortium is to establish an enduring partnership and to develop expertise to further develop and investigate safe and effective CAM treatments for infectious diseases of humans (and animals).A first ongoing project on the development of safe and effective bio-based CAM antimycotics in women with (recurrent) vaginal candidiasis infection is introduced.